Article

Comparative Effectiveness of the SARS-CoV-2 Vaccines During Delta Dominance

2022-12-28

Abstract excerpt

Background: Several vaccines with demonstrated efficacy for coronavirus disease 2019 (Covid-19) are available. The vaccines’ differential effectiveness may have significant impacts, but information on comparative efficacy in large populations is limited. <br><br>Methods: We used de-identified claims in a research database that included vaccination status and Covid-positivity status. Individuals > 18 years, fully...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e8d36032-2a74-52e9-ba13-a01bd369cbd3
DOI: 10.2139/ssrn.4257527

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Comparative Effectiveness of the SARS-CoV-2 Vaccines During Delta DominanceDOI 10.2139/ssrn.4257527Read

Comparative Effectiveness of the SARS-CoV-2 Vaccines During Delta DominanceSemantic proximity Read

Comparative Effectiveness of mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Older Adults: Systematic Literature Review and Meta-Analysis Using the GRADE FrameworkSemantic proximity Read

Clinical and Economic Impact of Differential COVID-19 Vaccine Effectiveness in the United StatesSemantic proximity Read

Effectiveness of mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infections during the Delta variant epidemic in Japan: Vaccine Effectiveness Real-time Surveillance for SARS-CoV-2 (VERSUS)Semantic proximity Read

Comparative Effectiveness of the mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Adults With Underlying Medical Conditions: A Systematic Literature Review and Pairwise Meta-Analysis Using GRADESemantic proximity Read

Effectiveness of Covid-19 vaccines against symptomatic and asymptomatic SARS-CoV-2 infections in an urgent care settingSemantic proximity Read

Expert Review of Global Real-World Vaccine Effectiveness Against SARS-CoV-2Semantic proximity Read

Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalenceSemantic proximity Read

Comparative effectiveness of mRNA-1273 and BNT162b2 against symptomatic SARS-CoV-2 infectionSemantic proximity Read

Comparative effectiveness of mRNA-1273 versus protein-based NVX-CoV2705 vaccination on COVID-19-related outcomes among US insured adults during 2024–2025: a retrospective matched cohort studySemantic proximity Read

Comparative analysis of human immune responses following SARS-CoV-2 vaccination with BNT162b2, mRNA-1273, or Ad26.COV2.SSemantic proximity Read

Effectiveness of the Single-Dose Ad26.COV2.S COVID VaccineSemantic proximity Read